This compound is primarily utilized in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various biologically active molecules, particularly in the synthesis of protease inhibitors and other therapeutic agents. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in drug discovery and material science. Additionally, its structure, featuring both a piperazine moiety and a boronic acid group, enhances its potential in targeting enzymes and receptors involved in disease pathways, making it a promising candidate for medicinal chemistry applications.